{
  "newspaper_id": "economynextcom",
  "url": "https://economynext.com/nu-life-biotech-to-manufacture-antibiotics-in-sri-lanka-147760/",
  "time_ut": 1705565580.0,
  "original_lang": "en",
  "original_title": "Nu Life Biotech to manufacture antibiotics in Sri Lanka",
  "original_body_lines": [
    "ECONOMYNEXT \u2013 Nu Life Biotech Pvt Ltd started construction work on its Carbapenem injectables manufacturing facility at the \u2018Suwa Siri Pura\u2019 pharmaceutical production zone in Oyamaduwa, Anuradhapura, this week.",
    "The company\u2019s Penem Injectable Facility will be planned, designed, engineered as per GMP Standards of NMRA, WHO, EU and PIC/S etc, it said in a statement. \u201cThe facility will conform to all relevant local statutory and regulatory requirements.\u201d",
    "Carbapenems are used to treat severe infections, including drug-resistant infections caused by bacteria, and are given by injection as opposed to orally.",
    "This is the second pharmaceutical manufacturing plant to be built in the dedicated zone. Neolina Holdings Pvt Ltd laid the foundation stone in Suwa Siri Pura to manufacture Pharmaceutical Products in 2022.",
    "The \u2018Suwa Siri Pura\u2019 pharmaceutical manufacturing zone will create 2,000 direct jobs and 5,000 indirect jobs, a State information office statement said.",
    "\u201cAround 85 acres of land has been allocated for the construction of 21 pharmaceutical factories. Around 2,000 direct jobs and 5,000 indirect jobs are to be created,\u201d the statement said.",
    "Sri Lanka spends around 120 billion rupees to import medicines, according to the statement, and only 20 percent of the country\u2019s pharmaceutical needs are met through the local manufacture of medicine.",
    "\u201cThe aim is to produce 80% of the requirement and the surplus production is expected to be exported,\u201d the statement read. (Colombo/Jan18/2024)"
  ]
}